Hypertension in China: Past, present, and future

Current Hypertension Reviews

Volumn 4, Issue 4, 2008, Pages 241-244

  Kwan, Tak W ^a,b,h   Yu, Christine ^c   Zheng, Yixiu ^d   Kwan, Joanne ^e   Stein, Richard A ^a   Chen, Shaoliang ^f   Hu, Dayi ^g  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c Department of Medicine   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e NEW YORK UNIVERSITY   (United States)

^f NANJING MEDICAL UNIVERSITY   (China)

^g PEKING UNIVERSITY   (China)

^h NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CAPTOPRIL; CHINESE DRUG; DIHYDRALAZINE; ENALAPRIL; FELODIPINE; GINSENG EXTRACT; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LOSARTAN; NITRENDIPINE; QINGXUE DAN; RESERPINE; SALVIA MILTIORRHIZA EXTRACT; TRIAMTERENE; UNCLASSIFIED DRUG;

ACUPUNCTURE; ALCOHOL CONSUMPTION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHINA; CLINICAL TRIAL; DIET THERAPY; DISEASE PREDISPOSITION; EDUCATIONAL STATUS; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LIPID DIET; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; RURAL AREA; SALT INTAKE; STROKE; TREND STUDY;

EID: 70350004091     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340208786241318     Document Type: Review

References (42)

1. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-23.
2. He J, Gu DF, Wu XG, et al. Major causes of death among men and women in China. N Engl J Med 2005; 53:1124-34.
3. Gu DF, Reynolds K, Wu XG, et al. for the InterASIA Collaborative Group. Prevalence, Awareness, Treatment, and Control of Hypertension in China. J Hypertens 2002; 40:920-927.
4. Liu LS. Hypertension: Chinese experiences 1958-1996. Chinese Med J 1997; 110:7-10.
5. Wu XG, Duan XF, Gu DF, et al. Prevalence of hypertension and its trends in Chinese populations. Int J Cardiol 1995; 52:39-44.
6. Ueshima H, Zhang XH, Choudhury SR. Epidemiology of hypertension in China and Japan. J Hum Hypertens 2000; 14:765-769.
7. Pan WH, Chang HY, Yeh WT, et al. Prevalence, awareness, treatment and control of hypertension in Taiwan: results of Nutrition and Health Survey in Taiwan (NAHSIT) 1993-1996. J Hum Hypertens 2001; 15:793-798.
8. Wu XG, Huang ZD, Stamler J, et al. on behalf of the PRC-USA Cardiovascular and Cardiopulmonary Epidemiology Research Group. Changes in average blood pressure and incidence of high blood pressure 1983-1984 to 1987-1988 in four population cohorts in the Popple's Republic of China. J Hypertens 1996; 14:1267-74.
9. Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003; 21:707-716.
10. Wang Z, Wu Y, Zhao L, et al. Trends in prevalence, awareness, treatment and control of hypertension in the middle-aged population of China, 1992-1998. Hypertens Res 2004; 27:703-709.
11. Kim J, Jones D, Kim S, et al. Hypertension in Korea: a national survey. Am J Prev Med 1994; 10:200-204.
12. Joffres MR, Ghadirian P, Fodor JG, et al. Awareness, treatment and control of hypertension in Canada. Am J Hypertens 1997; 10:1097-1102.
13. Sun ZQ, Zheng LQ, Wei YD, et al. Prevalence and risk factors of the rural adult people prehypertension status in Liaoning province of China. Circ J 2007; 71:550-553.
14. Huang ZD, Wu XG, Stamler J, et al. A north-south comparison of blood pressure and factors related to blood pressure in the People's Republic of China: a report from the PRC-USA Collaborative Study of Cardiovascular Epidemiology. J Hypertens 1994; 12: 1103-12.
15. Zhao LC, Stamler J, Yan LL, et al. for the INTERMAP Research Group. Blood pressure differences between Northern and Southern Chinese: Role of dietary factors: the international study on macro-nutrients and blood pressure. J Hypertens 2004; 43:1332-37.
16. Reynolds K, Gu DF, Muntner Paul, et al. for the InterASIA Collaborative Group. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens 2003; 21:1273-81.
17. He J, Klag MJ, Whelton PK, et al. Body mass and blood pressure in a lean population in southwestern China. Am J Epidemiol 1994; 139:380-389.
18. Liu LS, Xie JX, Gang WQ. Urinary cations and blood pressure: a collaborative study of 16 districts in China. J Hypertens 1988; 6:S587-S590.
19. Stamler R, Liu LS, Nichols R, et al. Blood pressure and life style in the Peoples's Republic of China: three samples in the INTERSALT Study. J Hum Hypertens 1993; 7:429-435.
20. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the Health Examination Surveys, 1960 to 1991. Hypertension 1995; 26:60-90.
21. Li W, Jiang XJ, Ma H, et al. Awareness, treatment and control of hypertension in patients attending hospital clinics in China. J Hypertens 2003; 21:1191-97.
22. Dong GH, Sun ZQ, Zheng LQ, et al. Prevalence, awareness, treatment, and control of hypertensionin rural adults from Liaoning province, Northest China. Hypertens Res 2007; 30:951-958.
23. Dunbabin DW, Sandercock PAG. Preventing stroke by modification of risk factors. Stroke 1990; 21(suppl IV): IV36-IV39.
24. Zhang XF, Attia J, D'Este C, et al. The relationship between higher blood pressure and ischaemic, haemorrhagic stroke among Chinese and Caucasians: meta-analysis. Eur J Cardiovasc Prev Rehabil 2006; 13: 429-437.
25. Eastern Stroke and Coronary Heart Disease Collaborative Group. Blood pressure, cholesterol and stroke in Eastern Asia. Lancet 1998; 352:1081-07.
26. Zhou BF, Zhang HY, Wu YF, et al. Ecological analysis of the association between incidence and risk factors of coronary heart disease and stroke in Chinese population. CVD Prev 1998; 1:207-216.
27. Zhao, SP, Mao JW, Hu JP. The analysis of population mortality rate and causes of death in urban and rural areas of China. Chin J Health Stat 1999; 16:276-280.
28. Yin RX, Wu JZ, Lin WX, et al. Effects of alcohol consumption and other lifestyle behaviors on blood pressure for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han populations. Alcohol 2007; 41:541-550.
29. INTERSALT Cooperative Research Group. INTERSALT: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988; 297:319-328.
30. Lin SG, Cheng TO, Liu XQ, et al. Impact of dysglycemia, body mass index, and waist-to-hip ratio on the prevalence of systemic hypertension in a lean Chinese population. Am J Cardio 2006; 97: 839-842.
31. He J, Muntner P, Chen J, et al. Factors associated with hypertension control in the general population of the United States. Arch Intern Med 2002; 162:1051-58.
32. Liu L, Wang JG, Gong L, Liu G, Staessen JA. for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo for older patients with isolated systolic hypertension. J Hypertens 1998; 16:1823-1829.
33. Wang JG, Liu G, Wang X, et al. Long-term blood pressure control in older Chinese patients with isolated systolic hypertension: a progress report on the Syst-China trial. J Hum Hypertens 1996; 10: 35-742.
34. Fang, XH, Kronmal RA, Li SC, et al. Prevention of stroke in urban China: A community-based intervention trial. Stroke 1999; 30: 495-501.
35. Liu LS, Zhang YQ, Liu GZ, et al. The felodipine event reduction (FEVER) study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens 2005; 23: 2157-72.
36. Wang JG, Staessen JA, Gong LS, et al. for the Syst-China collaborative group. Chinese trial on isolated systolic hypertension in the Elderly. Arch Intern Med 2000; 160: 211-220.
37. Kim ND, Kang SY, Kim MJ, et al. The Ginsenoside Rg3 evokes endothelium-independent relaxation in rat aortic rings: role of K+ channels. Eur J Pharmcol 1999; 367: 51-57.
38. Kim KK, Sanchez FA, Duran RG, et al. Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension. Am J Physiol Heart Circ Physiol 2007; 292: H2131-37.
39. Yun SP, Jung WS, Park SU, et al. Anti-hypertensive effect of Chunghyul-dan (Qingxue-dan) on stroke patients with essential hypertension. Am J Chin Med 2005; 33: 357-364.
40. Macklin EA, Wayne PM, Kalish LA, et al. Stop hypertension with the acupuncture research program (SHARP): results of a randomized, controlled clinical trial. Hypertens 2006; 48: 835-845.
41. Flachskampf FA, Gallasch J, Gefeller O, et al. Randomized trial of acupuncture to lower blood pressure. Circulation 2007; 115: 3048-49.
42. Yin C, Seo B, Park HJ, et al. Acupuncture, a promising adjunctive therapy for essential hypertension, a double-blind randomized, controlled trial. Neurol Res 2007; 29: S98-103.